Cargando…

Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana

Background: Cryptococcal antigen (CrAg) screening in individuals with advanced HIV reduces cryptococcal meningitis (CM) cases and deaths. The World Health Organization recently recommended increasing screening thresholds from CD4 ≤100 cells/µL to ≤200 cells/µL. CrAg screening at CD4 ≤100 cells/µL is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tenforde, Mark W., Muthoga, Charles, Ponatshego, Ponego, Ngidi, Julia, Mine, Madisa, Greene, Greg, Jordan, Alexander, Chiller, Tom, Larson, Bruce A., Jarvis, Joseph N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767426/ https://www.ncbi.nlm.nih.gov/pubmed/35087954 http://dx.doi.org/10.12688/wellcomeopenres.16624.2

Ejemplares similares

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2020)

Evaluation of a Novel Semiquantitative Cryptococcal Antigen Lateral Flow Assay in Patients with Advanced HIV Disease
por: Jarvis, Joseph N., et al.
Publicado: (2020)

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
por: Tenforde, Mark W., et al.
Publicado: (2020)

Prevalence and Associated Factors of Cryptococcal Antigenemia in HIV-Infected Patients with CD4 < 200 Cells/µL in São Paulo, Brazil: A Bayesian Analysis
por: Mimicos, Evanthia Vetos, et al.
Publicado: (2022)

Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review
por: Costiniuk, Cecilia T., et al.
Publicado: (2011)

Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs
por: Larson, Bruce, et al.
Publicado: (2022)

A Retrospective Nationwide Non-Interventional Study of an Aqueous Sublingual Immunotherapy Formulation Administered with a 200-µL Dosing Pump
por: Roger Reig, Albert, et al.
Publicado: (2021)

Nontuberculous Mycobacteria, Botswana, 2011–2014
por: Mbeha, Bontle, et al.
Publicado: (2019)

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial
por: Meya, David B., et al.
Publicado: (2019)

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis
por: Ford, Nathan, et al.
Publicado: (2018)

µFBI: A Microfluidic Bead-Based Immunoassay for Multiplexed Detection of Proteins from a µL Sample Volume
por: Yu, Xiaobo, et al.
Publicado: (2010)

Deep-diving pilot whales make cheap, but powerful, echolocation clicks with 50 µL of air
por: Foskolos, Ilias, et al.
Publicado: (2019)

Profiling extracellular vesicle surface proteins with 10 µL peripheral plasma within 4 h
por: He, Jie, et al.
Publicado: (2023)

Detecting Bacterial Cell Viability in Few µL Solutions from Impedance Measurements on Silicon-Based Biochips
por: Bhat, Vinayak J., et al.
Publicado: (2021)

Immune correlates of HIV-associated cryptococcal meningitis
por: Tenforde, Mark W., et al.
Publicado: (2017)

ZIC-cHILIC Functionalized Magnetic Nanoparticle for Rapid and Sensitive Glycopeptide Enrichment from <1 µL Serum
por: Pradita, Tiara, et al.
Publicado: (2021)

Laboratory Evaluation of the VISITECT Advanced Disease Semiquantitative Point-of-Care CD4 Test
por: Lechiile, Kwana, et al.
Publicado: (2022)

Treatment for HIV‐associated cryptococcal meningitis
por: Tenforde, Mark W, et al.
Publicado: (2018)

Impedance analysis of adherent cells after in situ electroporation-mediated delivery of bioactive proteins, DNA and nanoparticles in µL-volumes
por: Stolwijk, Judith A., et al.
Publicado: (2020)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2022)

Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study
por: Tenforde, Mark W, et al.
Publicado: (2019)

HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings
por: Tenforde, Mark W., et al.
Publicado: (2016)

PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse
por: Autilio, Chiara, et al.
Publicado: (2017)

HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study
por: Dorward, Jienchi, et al.
Publicado: (2020)

CCNA routing and switching review guide: exams 100-101, 200-101, and 200-120
por: Lammle, Todd
Publicado: (2013)

CCNA routing and switching study guide: exams 100-101, 200-101, and 200-120
por: Lammle, Todd
Publicado: (2013)

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
por: Atkinson, Andrew, et al.
Publicado: (2021)

Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa
por: Larson, Bruce A., et al.
Publicado: (2016)

HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
por: Kelentse, Nametso, et al.
Publicado: (2020)

Human papillomavirus prevalence in male and female university students in Gaborone, Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
por: Rajasingham, Radha, et al.
Publicado: (2019)

CCNA routing and switching deluxe study guide: exam 100-101, exam 200-101, exam 200-120
por: Lammle, Todd, et al.
Publicado: (2014)

Todd Lammle's CCNA/CCENT IOS Commands Survival Guide: Exams 100-101, 200-101, and 200-120
por: Lammle, Todd
Publicado: (2014)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

Five years after Treat All implementation: Botswana’s HIV response and future directions in the era of COVID-19
por: Jefferis, Keith, et al.
Publicado: (2021)

Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review
por: Bango, Zackary Austin, et al.
Publicado: (2020)

Optimizing HIV treatment through point-of-care CD4 testing – ACHAP Botswana community-based pilot
por: Mugisha, Kenneth, et al.
Publicado: (2014)

The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda
por: Lawrence, David S., et al.
Publicado: (2022)

The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
por: Li, Yao, et al.
Publicado: (2020)

High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda
por: Byonanebye, Dathan M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hip4otfi11qhnfapt6v7cfdqo8